PULMOTEC

This brand name is authorized in France, Ireland, Spain.

Active ingredients

The drug PULMOTEC contains one active pharmaceutical ingredient (API):

1	Technetium ⁹⁹ᵐTc technegas UNII 4QQN74LH4O - GRAPHITE
	Technetium-99m technegas is used for the scintigraphy of alveolar spaces, in particular in the context of the diagnosis of pulmonary embolism. In the concentrations used for diagnostic examinations, technegas is an inert suspension and has no pharmacological effect.
	Read more about Technetium ⁹⁹ᵐTc technegas

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PULMOTEC Kit for radiopharmaceutical preparation	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V09EA02	Technetium (99mTc) technegas	V Various → V09 Diagnostic radiopharmaceuticals → V09E Respiratory system → V09EA Technetium (99mTc), inhalants
Discover more medicines within V09EA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
ES	Centro de información online de medicamentos de la AEMPS	63210
FR	Base de données publique des médicaments	60424605